IGM Biosciences’ $230 Million Public Offering

Wilson Sonsini Goodrich & Rosati advised IGM on the transaction.IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its non-voting…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now